Profile
Amir Gross is the founder of Valtech Cardio Ltd., where he holds the title of Chief Executive Officer starting in 2014.
He is currently the Chief Executive Officer at Cardiovalve Ltd.
Mr. Gross previously worked as a Director at Neurosense Therapeutics Ltd.
Amir Gross active positions
| Companies | Position | Start |
|---|---|---|
Valtech Cardio Ltd.
 Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Chief Executive Officer | 31/10/2006 |
Cardiovalve Ltd.
 Cardiovalve Ltd. Medical SpecialtiesHealth Technology Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million. | Chief Executive Officer | - |
Former positions of Amir Gross
| Companies | Position | End |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Valtech Cardio Ltd.
Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Health Technology |
Cardiovalve Ltd.
Cardiovalve Ltd. Medical SpecialtiesHealth Technology Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million. | Health Technology |
- Stock Market
- Insiders
- Amir Gross
